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ABSTRACT
Objective To evaluate the effectiveness of the systematic
use of a transparent plastic collector bag to measure
postpartum blood loss after vaginal delivery in reducing
the incidence of severe postpartum haemorrhage.
Design Cluster randomised trial.
Setting 13 European countries.
Participants 78 maternity units and 25381 women who
had a vaginal delivery.
Interventions Maternity units were randomly assigned to
systematicuseofacollectorbag(interventiongroup)orto
continue to visually assess postpartum blood loss after
vaginal delivery (control group).
Main outcome measures The primary outcome was the
incidence of severe postpartum haemorrhage in vaginal
deliveries,definedasacompositeofoneormoreofblood
transfusion, intravenous plasma expansion, arterial
embolisation, surgical procedure, admission to an
intensivecareunit,treatmentwithrecombinantfactorVII,
and death.
ResultsSevere postpartumhaemorrhage occurredin 189
of11037ofvaginaldeliveries(1.71%)intheintervention
group compared with 295 of 14344 in the control group
(2.06%). The difference was not statistically significant
either in individual level analysis (adjusted odds ratio
0.82, 95% confidence interval 0.26 to 2.53) or in cluster
level analysis (difference in weighted mean rate adjusted
forbaselinerate 0.16%,95%confidenceinterval −0.69%
to 1.02%).
Conclusion Compared with visual estimation of
postpartum blood loss the use of a collector bag after
vaginal delivery did not reduce the rate of severe
postpartum haemorrhage.
Trial registration Current Controlled Trials
ISRCTN66197422.
INTRODUCTION
Worldwide, postpartum haemorrhage remains one of
the leading causes of maternal mortality
1 and the main
component of severe morbidity,
2-5 jeopardising
women’sfertility,exposingthemtorisksoftransfusion
andintensivecare,andincurringcosts.Fromreportsin
developed countries, about 1% of deliveries are asso-
ciated with severe postpartum haemorrhage.
3-6
Decreasing the prevalence of severe postpartum
haemorrhage remains a challenge. This seems all the
more important given the recent increase in the inci-
dence of postpartum haemorrhage reported in several
developed countries.
278 Individual risk factors have
been describedbut they poorly predict the occurrence
ofpostpartumhaemorrhage.
910Interesthasfocusedon
care processes, as they are potentially amenable to
change. Studies of maternal deaths show that most
deaths due to postpartum haemorrhage involve
delayed and substandard care in the diagnosis and
management of blood loss.
11-13 Similar findings were
drawn from a population based study of severe non-
lethal postpartum haemorrhage.
14
Delay in the diagnosis and treatment of postpartum
haemorrhage may result from an underestimation of
blood loss at delivery. Assessment of postpartum
blood loss, particularly after vaginal birth, is recog-
nised as difficult. Many studies found that visual
estimates of peripartum blood loss are often
inaccurate,
15-21 showing an overestimation of blood
loss at low volumes and an underestimation at larger
volumes, the magnitude of underestimation typically
increasing with the volume of haemorrhage.
We hypothesised that if blood loss is monitored and
objectively measured by collection in a transparent
plastic bag rather than by visual assessment, the
response of a care giver will be triggered more rapidly
when excessive blood loss occurs. Specifically, when
bleeding is excessive but before haemorrhage has
become catastrophic, appropriate management will
take place without delay, so reducing the incidence of
severe postpartum haemorrhage. A preliminary study
hasshownthataplasticcollectorbagconstitutesasim-
ple instrument for diagnosing haemorrhage in the
delivery room.
22 The impact of its use on health out-
comes related to postpartum haemorrhage has, how-
ever, never been tested. Despite lacking evidence, the
bag is routinely used in many maternity units in Bel-
gium, France, Italy, and Portugal (European Union
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Weevaluatedtheeffectivenessofsystematicuseofa
transparent plastic collector bag to measure postpar-
tum blood loss after vaginal delivery in reducing the
incidence of severe postpartum haemorrhage.
METHODS
We used a cluster randomised design with maternity
unitastheunitofrandomisation.Giventhelogisticsof
clinical practice on the delivery suite, contamination
seemedtobeinevitableinanindividualpatientrando-
mised trial setting. The sites we selected for the trial
comprised 78 maternity units in 13 European coun-
tries (table 1). Maternity units were eligible if they
hadmorethan200vaginaldeliveriesannually(exclud-
ingwaterbirths)andnopreviouspolicyforroutineuse
of collector bags. In addition, to ensure that the stan-
dard of care for management of the third stage of
labour was similar across all participating units, the
unitshadtocomplywiththeEUPHRATESconsensus
statement on the prevention and management of post-
partum haemorrhage,
24 a minimum standard, not a
detailed guideline.
In all maternity units of participating countries
except Denmark, we included all women undergoing
a vaginal delivery during the study period. In Den-
mark, enrolment into the study in each maternity unit
depended on the midwife; if a midwife agreed to parti-
cipate,weincludedallofthevaginaldeliveriesthatshe
or he took care of in their maternity unit.
The random allocation was produced centrally by
the National Perinatal Epidemiology Unit, Oxford. A
stratifieddesignwasusedtoensurethatthetwoarmsof
the trial were as similar as possible at baseline for the
stratification factors of country and size of maternity
unit (median split within country). The maternity
units were randomly allocated to either systematic
use of a collector bag after vaginal delivery (inter-
vention arm) or no use of the bag (control group).
Intervention
The trial was implemented between January 2006 and
May2007,dependingonthecountry.Beforeparticipa-
tion, each centre was visited by the national coordina-
tor. At the visit, staff were reminded of the
EUPHRATES consensus statement on the prevention
and management of postpartum haemorrhage and
familiarised with the processes and the data collection
instrument.
A second visit from the national coordinator took
place in the intervention group after randomisation,
when use of the collector bag was explained to birth
attendantswith the aid of standard written instructions
and a training video. The bag was to be placed under
the mother’s pelvis as soon as the baby was born and
before delivery of the placenta. The bag was transpar-
ent and graduated, allowing continuous monitoring of
blood loss. It did not require sterilisation and could be
used in the dorsal, lateral, or lithotomy positions.
Women delivering standing or crouching could be
offered the opportunity to lie down for the third
stage, allowing the bag to be placed under their pelvis.
The bag was to be left in situ until the birth attendant
was no longer concerned about blood loss, such as
when a sanitary towel was applied to the vulva. Bags
were purchased centrally and provided to each cluster
in the intervention arm.
No collector bagwas usedin the controlgroup, with
postpartum blood loss being assessed visually. The
control group was monitored during the study period
to assess compliance with allocation.
Outcomes
Theprimaryoutcomewastheincidenceofseverepost-
partum haemorrhage after vaginal deliveries, defined
as a composite of all women who experienced one or
Table 1 |Number of maternity units and women in baseline and trial periods by allocation and by country*
Country
Maternity units Women
Intervention Control Total No (%)
Baseline period Trial period
Total Intervention Control Total Intervention Control
Austria 3 3 1067 (3.0) 371 219 152 696 359 337
Belgium 8 8 6013 (17.1) 1552 728 824 4461 1867 2594
Denmark 3 3 1657 (4.7) 507 272 235 1150 562 588
Finland 2 2 4805 (13.7) 1347 656 691 3458 1551 1907
France 3 3 3702 (10.6) 972 544 428 2730 1351 1379
Hungary 4 4 2230 (6.4) 562 268 294 1668 784 884
Ireland 2 2 3971 (11.3) 950 300 650 3021 946 2075
Italy 3 3 926 (2.6) 196 138 58 730 491 239
Netherlands 1 1 1084 (3.1) 301 130 171 783 322 461
Norway 1 1 668 (1.9) 143 72 71 525 241 284
Portugal 2 3 3274 (9.3) 810 338 472 2464 901 1563
Spain 4 3 4351 (12.4) 1595 1097 498 2756 1239 1517
Switzerland 3 3 1328 (3.8) 389 175 214 939 423 516
Total 39 39 35 076 (100) 9695 4937 4758 25 381 11 037 14 344
*Baseline data were unavailable in one maternity unit in intervention group.
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sion, arterial embolisation, surgical procedure, admis-
sion to an intensive care unit, treatment with
recombinant factor VII, and death. Secondary out-
comes were each of the components of the primary
outcome, manual removal of the placenta, and admin-
istration of prostaglandins after delivery.
Data collection
Each participating centre was asked to collect data for
four months from all women who had had a vaginal
delivery: for one month before randomisation (base-
line period) and for three months after randomisation
in the control group (trial period). The three month
period of data collection in the intervention group fol-
lowedatwoweektrainingperiodduringwhichtheunit
started using the collector bag.
Datawerecollectedusingaformfilledinbythebirth
attendants for each vaginal delivery. Information was
collected on maternal age, induction of labour, mode
ofdelivery, numberofbabies,birthweight,use of pro-
phylactic uterotonics, and outcome data. A second
form was used for deliveries with severe postpartum
haemorrhage, with information collected on the deliv-
ery and management of postpartum haemorrhage.
This form was used to cross check criteria for the pri-
mary outcome.
Sample size
The sample size calculation took into account the clus-
ter randomised design; we estimated the intracluster
correlationcoefficienttobe0.01. Withthe assumption
ofaneventratefortheprimaryoutcomeof2.5%inthe
control group, 82 clusters (41 in each arm of the trial)
were required to detect a decrease in the event rate to
1.5%(a40%relativeriskreduction)with80%power,a
twosidedsignificancelevelof5%,andanaverageclus-
ter size of 300 women.
25
Statistical analysis
The participants and maternity units were analysed in
the groups to which they were assigned regardless of
the management received by individual women or
deviation from the protocol.
We summarised the baseline characteristics of the
maternity units and individual women using counts
(percentages) for categorical variables, means (stan-
dard deviations) for normally distributed continuous
variables, or medians (interquartile ranges) for other
continuous variables. Comparative statistical analysis
was done at both individual and cluster level and took
into account the effect of clustering. All statistical tests
weretwosided(5%significancelevel)andnotadjusted
for multiple comparisons. Statistical analyses were
done using SPSS version 17 and Stata v10.0 software.
Foranalysisattheindividuallevelwecomparedpri-
mary and secondary outcomes between the two study
groups both unadjusted and adjusted for the effect of
clustering. To determine the magnitude and direction
of any differences in outcomes between the two
groups, we calculated crude odds ratios and 95% con-
fidence intervals. We also used logistic regression to
adjust for clustering and key prognostic factors. The
cluster randomised design imparts a data structure
thatfacilitatesthecalculationofavalidintraclustercor-
relation coefficient, ρ.
Cluster level analysis was carried out only on the
primary outcome. Some hospitals contributed fewer
events than others and some recruited fewer women.
We allowed these hospitals to have less effect on the
treatment estimate by weighting the analysis on the
basis of the precision—that is, we calculated the
weighted mean difference for the treatment compari-
son.Weusedaweightedlinearregressionmodeltotest
the effect of the intervention on the rate of severe post-
partum haemorrhage during the trial period, adjusting
for the baseline rate, expressed as the weighted mean
difference (95% confidence interval).
RESULTS
Figure 1 shows the flow of maternity units and women
through the study. Of the 84 maternity units meeting
the inclusion criteria, two declined to participate
beforeallocation.Overall,41maternityunitswereran-
domised to the intervention group and 41 to the con-
trol group. Two maternity units in each group opted
out before receiving notification of allocation owing
to lack of necessary resources. Thirty nine in each
group completed the trial. Table 1 shows the number
ofparticipatingmaternityunitsandwomenincludedin
each country.
Onematernityunitintheinterventiongroupdidnot
collect baseline data. Deviating from the protocol,
most maternity units (31 of 39) continued collecting
data during the two week training period in the inter-
vention arm.In these units,trial data collection started
Allocated to control (maternity units=41):
  Received notification of allocation (n=39)
  Did not receive notification of allocation (n=2)
    Lacked necessary resources and opted out
    before receiving notification of allocation
Allocated to collector bag (maternity units=41):
  Received notification of allocation (n=39)
  Did not receive notification of allocation (n=2)
    Lacked necessary resources and opted out
    before receiving notification of allocation
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Eligible maternity units or clusters (n=84)
Random allocation stratified on cluster size within country (n=82)
Baseline assessment:
  Maternity units (n=39)
  Women (n=4758)
  Median cluster size 93
    (interquartile range 44-162)
Baseline assessment:
  Maternity units (n=39)
  Women (n=4937)
  Median cluster size 85
    (interquartile range 51-167)
Analysed:
  Maternity units (n=39)
  Women (n=14 344)
  Median cluster size 284
    (interquartile range 113-499)
Analysed:
  Maternity units (n=39)
  Women (n=11 037) 
  Median cluster size 241
    (interquartile range 148-408)
Lost to follow-up (n=0) Lost to follow-up (n=0)
Declined to participate (n=2)
Fig 1 | Flow diagram of trial
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units in the control group collected trial data for more
than three months (up to five months). Only the three
month period of data collection specified in the proto-
col was considered for all units. In some Austrian hos-
pitals the number of women included was low, given
the total expected number of deliveries. The national
coordinator confirmed that the missing data were all
caesareandeliveriesandthatinsomehospitalsthecae-
sareanratewashigh.Nevertheless,sensitivityanalyses
were carried out and showed that the results were not
influenced by excluding these hospitals or even the
entire Austrian dataset.
Baseline data were collected for 4937 vaginal deliv-
eries in the intervention group and 4758 in the control
group. The characteristics of the maternity units and
women (table 2) in both groups were broadly similar
for all factors except manual removal of the placenta
and use of prophylactic uterotonics, which were more
common among women in the intervention group.
Primary outcome
Individual level analysis
A total of 25381 women were included in the analysis
(11037intheinterventiongroup,14344inthecontrol
group). The greater number of women in the control
groupresultedfromalargermedianclustersize(241in
the intervention group, 284 in the control group).
The incidence of severe postpartum haemorrhage
was 189 of 11037 vaginal deliveries (1.71%) in the
intervention group compared with 295 of 14344 in
the control group (2.06%). The difference was not sta-
tistically significant (table 3). The crude odds ratio for
theeffectoftheinterventionwas0.83(95%confidence
interval 0.69 to 1.00). The odds ratio adjusted for clus-
tering was 0.83 (0.27 to 2.60); after further adjustment
formaternalage,useofprophylacticuterotonicsinthe
third stage, mode of delivery, and birth weight, the
odds ratio was 0.82 (0.26 to 2.53). Sensitivity analyses
weredonetotesttherobustnessofthisresultexcluding
unitsthatdeviatedfromtheprotocol,andalsobycoun-
try and baseline rate of severe postpartum haemor-
rhage (median split by country). The results of these
analyses were similar.
Cluster level analysis
The weighted mean rate for severe postpartum hae-
morrhage was 1.71% (SD 2.51%) in the intervention
group and 2.06% (SD 3.52%) in the control group.
The intracluster correlationcoefficient forsevere post-
partum haemorrhage was 0.023. The rate of severe
postpartum haemorrhage did not differ significantly
between the groups: weighted mean difference
−0.34% (95% confidence interval −2.56% to 1.87%);
P=0.75. Adjusting for the baseline rate of severe post-
partum haemorrhageresulted in a slight change in this
result: adjusted weighted mean difference 0.16%
(−0.69%to1.02%);P=0.70.Ratesofseverepostpartum
haemorrhage in the baseline and trial periods for each
maternity unit were heterogeneous across units in dif-
ferent countries (fig 2).
Figure 3 shows the difference in baseline and trial
rates of severe postpartum haemorrhage for each unit
in the intervention group, according to compliance
with bag use. No relation was found between the dif-
ferenceinseverepostpartumhaemorrhagerates(base-
lineandtrial)andtheproportionofbaguse.Analysisof
theinterventioneffectontheprimaryoutcome,includ-
ing in the intervention armonly maternity units where
the bag was used in at least 50% of vaginal deliveries,
showed no significant difference between the two
groups: individual level analysis adjusting for cluster
and individual characteristics, adjusted odds ratio
0.59 (95% confidence interval 0.23 to 1.53).
Secondary outcomes (individual level analysis)
Analysesweredonetotesttheeffectoftheintervention
on the main components of the primary outcome
(table 3). The proportion of women who had blood
transfusion, surgical procedure, embolisation, or man-
ual removal of placenta did not substantially differ
between the intervention and control groups, whether
after adjustment for cluster or after further adjustment
for other prognostic factors. No maternal deaths
occurred.
Table 2 |Baseline characteristics of maternity units and individual women by allocation.
Values are numbers (percentages) unless stated otherwise
Characteristics
Intervention group
(n=38)*
Control group
(n=39)
Maternity units:
Median (interquartile range) rate of caesarean
delivery (%)
21.1 (17.4-26.6) 21.7 (14.6-26.0)
>1600 deliveries annually 20 (52.6) 19 (48.7)
Maternal age (years): (n=4937) (n=4758)
Mean (SD) 29.6 (5.4) 29.7 (5.5)
Median (interquartile range) 30.0 (26-33) 30.0 (26-33)
No with missing data 31 23
Mode of delivery:
Spontaneous vaginal 4104 (83.1) 4062 (85.4)
Operative vaginal 833 (16.9) 696 (14.6)
Induction 1080 (21.9) 1043 (21.9)
No of babies:
Single 4833 (98.5) 4645 (98.6)
Multiple 76 (1.5) 68 (1.4)
No with missing data 28 45
Birth weight (g):
Mean (SD) 3315 (566.4) 3349 (549.1)
Median (interquartile range) 3330 (3020-3660) 3370 (3050-3690)
No with missing data 26 29
Prophylactic uterotonics in 3rd stage: 3527 (71.4) 3153 (66.3)
No with missing data 0 5
Prostaglandin used after birth: 212 (4.3) 218 (4.6)
No with missing data 0 5
Manual removal of placenta: 204 (4.1) 121 (2.5)
No with missing data 0 5
Severe postpartum haemorrhage† 60 (1.22) 90 (1.89)
*Baseline data unavailable in one maternity unit.
†One of following: maternal death, transfusion, plasma expansion, surgery or embolisation, admission to
intensive care unit, or treatment with recombinant factor VII.
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plasma expanders or prostaglandins differed between
intervention and control groups, but the differences
were not significant after adjustment for clustering
effect.
DISCUSSION
In thiscluster randomisedtrial of 25381 vaginaldeliv-
eries in 78 maternity units of 13 European countries,
thesystematicuseofacollectorbagaftervaginaldeliv-
ery did not modify the rate of severe postpartum hae-
morrhage. There was no evidence of heterogeneity,
the results not differing by country or size of hospital.
Strengths and limitations of the study
This trial provides new results on an unexplored
although controversial aspect of care in the third
stage of labour. Although objective measurement has
been shown to increase the accuracy of assessing post-
partum blood loss compared with visual
estimation,
15-21 the routine use of a collector bag was
not associated with a significant decrease in severe
postpartum haemorrhage. This result constitutes an
important contribution to the ongoing debate on stra-
tegies to improve the care of women with postpartum
haemorrhage and to decrease the incidence of severe
cases.Additionally,the clusterrandomiseddesignand
thelargenumberofclustersandtheirdiversityprovide
good external validity to this trial. Small deviations
from the protocol did occur for data collection, but
sensitivityanalysesshowedthatnoneofthesechanged
the internal validity of the trial.
Heterogeneity of baseline rates for severe postpar-
tum haemorrhage was large between maternity units
(0% to 13.4%). In theory such a variation should be
an asset and reflect a broad range of levels of risk in
the participating maternity units. Because these differ-
ences were strongly related to the country, however,
some concern remains about the criteria in use for the
management of postpartum haemorrhage in different
parts of Europe. Sensitivity analysis showed that this
aspect did not alter the results.
Baseline data showed some heterogeneity between
the intervention and control groups. Heterogeneity in
postpartum haemorrhage related practices and rates
has been reported across maternity units in Europe,
both between and within countries.
423Randomisation
should balance these differences between the two
arms. However, given the number of units rando-
mised, although large for a cluster randomised con-
trolled trial, there is a slight possibility of residual
imbalance. Analyses were, however, adjusted for the
main determinants of postpartum haemorrhage (indi-
vidual level analysis) and baseline rate of severe post-
partum haemorrhage (cluster level analysis); in
addition,sensitivityanalysisindicatedthattheabsence
of a major effect of the intervention was similar
whether the maternity units had a high or low baseline
rate of severe postpartum haemorrhage. In conse-
quence,any perceived or real imbalancein thesechar-
acteristicsshouldhavelittleornoeffectonthefindings.
Hypotheses for the results
Different mechanisms may explain the absence of dif-
ferenceintheratesofseverepostpartumhaemorrhage
between maternity units that used the bag and those
that visually assessed blood loss. This may result from
a lack of compliance to the intervention. This is, how-
ever, unlikely because of the persistent absence of dif-
ference between the two groups when the analysis was
Severe postpartum haemorrhage rate in baseline period (%)
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Fig 2 | Rate of severe postpartum haemorrhage during
baseline and trial periods for each maternity unit. Each dot
represents one maternity unit. Diagonal line denotes no
change in rate of postpartum haemorrhage from baseline to
trial period
Table 3 |Main outcomes. Values are numbers (percentages) unless stated otherwise
Outcomes
Intervention
(n=11 037)
Control
(n=14 344)
ICC
(ρ)
Crude odds ratio
(95% CI)
Adjusted odds ratio
(95% CI)†
Adjusted odds ratio
(95% CI)‡
Primary outcome:
Severe postpartum haemorrhage* 189 (1.71) 295 (2.06) 0.023 0.83 (0.69 to 1.00), P=0.05 0.83 (0.27 to 2.60), P=0.8 0.82 (0.26 to 2.53), P=0.7
Secondary outcomes:
Blood transfusion 86 (0.78) 135 (0.94) 0.011 0.83 (0.63 to 1.68), P=0.2 0.83 (0.35 to 1.96), P=0.8 0.80 (0.33 to 1.90), P=0.6
Plasma expander 127 (1.15) 222 (1.55) 0.022 0.74(0.59to0.92),P=0.007 0.74 (0.20 to 2.72), P=0.7 0.95 (0.62 to 1.46), P=1.0
Surgical procedure or embolisation 50 (0.45) 76 (0.53) 0.012 0.85 (0.60 to 1.22), P=0.9 0.85 (0.20 to 3.63), P=0.9 0.78 (0.18 to 3.40), P=0.7
Manual removal of placenta 326 (2.95) 366 (2.55) 0.016 1.16 (1.00 to 1.35), P=0.05 1.16 (0.76 to 1.77), P=0.5 1.09 (0.72 to 1.67), P=0.7
Prostaglandins 501 (4.54) 766 (5.34) 0.129 0.84(0.75to0.95),P=0.004 0.84 (0.40 to 1.77), P=0.7 0.85 (0.40 to 1.80), P=0.7
ICC=intracluster correlation coefficient.
*Defined by one of following: maternal death, transfusion, plasma expansion, surgery or embolisation, admission to intensive care unit, or treatment with recombinant factor VII.
†Adjusted for clustering (maternity unit).
‡Adjusted for clustering (maternity unit), age of mother, prophylactic uterotonics used in third stage, mode of delivery, and birth weight.
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high proportion of deliveries.
One potential reason for the apparent ineffective-
ness of the intervention might be incorrect use of the
bags; in particular, that they were covered most of the
timeandthuscouldnotbeviewed.Suchmisuseisunli-
kely to explain the observed lack of effect as detailed
oral and written instructions were provided and the
training video clearly showed the care giver watching
the bag and the graduations.
Participation in the study may indicate a particular
interest in the management of postpartum haemor-
rhage so that existing management had little room for
improvement. Such a selection process is, however,
unlikely in these maternity units, owing to the variety
of baseline rates of severe postpartum haemorrhage.
It may be hypothesised that the intervention has a
double effect, in two opposite directions: increasing
the rate of ascertainment through increased vigilance
anddecreasingtheprevalencethroughtimelymanage-
ment of excessive bleeding. If these two components
were of the same order of magnitude, the global effect
would be no effect. If this explanation was realistic,
however, different effect sizes would be expected
with different baseline rates or different degrees of
compliance, or both. None of this occurred, making it
unlikely that a benefit of the intervention in terms of
decreased severe outcome wasbalanced by an equiva-
lent increase in ascertainment. In fact the intervention
seemed to increase the rates of postpartum haemor-
rhage, reflecting that the intervention was possibly
more effective in improving ascertainment than in
changing practice.
A concomitant effect in the control group may also
have contributed to the absence of difference between
the two arms. Contamination of the intervention to
control units is unlikely since participating units were
notincontact,andnouseofbagswasreportedinallthe
control maternity units. Participation in a research
study, independently of any specific intervention, has
been reported to change behaviours of participants
(Hawthorne effect).
26 The hypothesis that the manage-
ment of postpartum haemorrhage would have
improved in the control arm is, however, not sup-
ported by the absence of change in the rate of severe
postpartum haemorrhage between the baseline and
trial periods in this group.
Themostplausibleexplanationofthenegativeresult
ofthistrialisthathavingamoreaccurateassessmentof
postpartum blood loss is not by itself sufficient to
change behaviours of care givers and improve the
management of postpartum haemorrhage. Lack of
identification of women with excessive postpartum
bleeding is a problem, potentially leading to higher
levels of medical intervention if the bleeding pro-
gressestoseverehaemorrhage.Wedesignedastrategy
to increase the awareness of care givers. The fact that
this has not translated into a change in clinical out-
comes probably reflects the complexity of decisions
onmanagement,whichareinfluencedbymultiplefac-
tors such as organisation of the delivery ward and how
care givers perceive and cope with emergencies.
Comparison with other studies
We did not find any other published study assessing
the effectiveness of the collector bag. We have, how-
ever, identified other large multicentre randomised
trials in the specialty of maternal and child health
where a diagnostic or screening test was evaluated
butwithoutanyassociatedinstructionsabouttheman-
agement of abnormal results.
27-29 None of these trials
showed benefit with the introduction of the test. In
addition one study showed that simple information is
not sufficienttohave an effectonthe readinessof birth
attendants to change.
30 These various reports suggest
that the effect of enhanced diagnostic methods should
include an accompanying protocol of management
and may be a specific behavioural intervention,
which in effect becomes a “complex intervention.”
Policy implications
The practical implication of these results for high
income countries is that those units that are using a
collector bag (cost per bag between €1 (88p; $1.44)
and €11 in Europe) need to reconsider their practice
and possibly reallocate the resources to other aspects
of care. Units that are not routinely using the bag
should keep the same policy. For resource poor coun-
tries, positive results with the use of the “kanga collec-
tor” have been reported.
31 This needs to be tested in a
randomised design. In the current context of reported
ongoing increase in the prevalence of postpartum hae-
morrhage, further research is needed to develop and
test effective strategies to decrease the prevalence of
severe postpartum haemorrhage through improve-
ment of management. These will probably be multifa-
ceted interventions, and in this context the collector
bag may warrant further investigation.
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